Early activation antigen CD69

BE0010487ProteinHumansCD69

Transmembrane protein expressed mainly on T-cells resident in mucosa that plays an essential role in immune cell homeostasis. It is acted on by 1 drug in DrugBank.

Gene name
CD69
UniProtKB entry
Q07108Swiss-Prot
Cellular location
Cell membrane
Residues / weight
199 residues · 22,559 Da
Also known as
Activation inducer molecule · AIM · BL-AC/P26 · C-type lectin domain family 2 member C · CLEC2C

Resolves to

Protein
UniProtQ07108UniProt nameCD69_HUMAN
Gene
HGNCHGNC:1694NCBI Gene969GeneCardsCD69
Pharmacology
KEGGhsa:969
Structure
PDB1E87PDB1E8IPDB1FM5
Drugs

What you can answer from here — as of October 31, 2023

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
8Clinical trialsTrials of drugs acting on it, by phase and status
Sign in
4GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which approved drugs act on Early activation antigen CD69, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In